TickerSpark Feed

SRPT coverage

Every article, report, and earnings note where SRPT appears.

Gene Therapy Stocks That Turn Science Into Sales: 7 Picks

A countdown of seven gene therapy stocks spans commercial treatments, gene-editing platforms, rare-disease specialists, and diversified pharmaceutical exposure.

Sep 22, 2026·13 MIN

gene therapy

SPAC

Should You Buy OHB Pediatrics Before the SPAC Merger Closes?

OHB Pediatrics, which trades as Oak Hill Bio, is going public through a merger with Research Alliance Corp III (Nasdaq: RACC) and expects to close by year-end 2026. The setup offers a Phase 3 rare-disease asset and committed financing, but shareholders should watch redemption risk and heavy dilution closely.

Jul 29, 2026·6 MIN

SPAC Merger De-SPAC

On-Demand Research

Want a deeper dive on SRPT?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate SRPT Report

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverCEG

▲15.47%

Constellation Energy Corporation · $309.03

Gene Therapy Stocks That Turn Science Into Sales: 7 Picks

Should You Buy OHB Pediatrics Before the SPAC Merger Closes?

Want a deeper dive on SRPT?

A new stock idea, every evening.

Stock research for every investor